Medtech startup Cureous Labs raises Rs 1.66 Cr in seed round led by IPV

Cureous Labs, a medical technology startup has raised Rs 1.66 crore in a seed funding round led by Inflection Point Ventures (IPV), with participation from Anthill Ventures. 

The funds will be used to produce the first batch of its flagship product Eturnal, build inventory, grow the sales and business development team, launch the first disinfection centre, and complete product safety testing and certifications. It also plans to expand its B2B product portfolio in India.

Read also- StampMyVisa Acquires Travel Tech Startup Teleport

Vinay Bansal, Founder of IPV said, “What drew us to invest in Cureous Labs is their commitment to the ‘Prevention is better than Cure’ idea. Around the world, there are several bedridden patients suffering from pressure injuries, adding to the already existing ailments. Additionally, it also puts strain on the caregivers, making it tedious and risky for them to care for the patients. Cureous Labs has used technology to ease the burden of care while making pressure injury prevention more affordable and accessible to organizations across the globe.”

Asish Mohandas, Founder and CEO, Cureous Labs said, “At Cureous, our mission is to create technologies that empower independent living. Eturnal™, our one-of-a-kind automated patient turning solution, helps prevent pressure injuries while reducing caregiver dependency and effort. We aim to build a portfolio of solutions for geriatric and long-term care. IPV’s early belief in our vision gives us the confidence and resources to scale Cureous into a category-defining company in this space.”

About Cureous Labs

Founded in 2019 by Asish Mohandas, Cureous Labs creates automated patient repositioning systems to prevent pressure injuries and enhance caregiver efficiency. 

Priced at one-fifth of international alternatives, the device is suited for hospitals, rehabilitation centres, and home care. The company reports over 30,000 hours of use and more than 14,000 automated patient turns.

With the global pressure injury prevention market valued at $277 bn and India’s opportunity estimated at $1.56 bn, Cureous Labs is well positioned to meet the rising demand for affordable, scalable elderly care solutions.

Advertisment